[1]
“In-silico Prediction of Binding Affinities and Pharmacokinetic Parameters of Indoline-2-one Derivatives as Anticancer HDAC Inhibitors”, AJPS, vol. 26, no. 1, pp. 80–99, Mar. 2026, doi: 10.32947/ajps.v26i1.1367.